Map of Pancreatica Walks and Runs

Category Archives: Pancreatic Cancer

Evaluating the Xeloda and Tarceva Oral Regimen for Advanced Pancreatic Cancer

Spanish research Fulgar and colleagues published a recent article in the journal Anticancer Research detailing the results of their multi-center Phase 2 clinical trial evaluating oral erlotinib (Tarceva – 150 mg per day) coupled with the also orally administered capecitabine (Xeloda).  Capecitabine is a pro-drug of 5-FU that becomes 5-fluorouracil in the course of its […]

Share Button

Phase 2 Results of Gemcitabine and Monoclonal Antibody for Advanced Pancreatic Cancer

It’s hard to keep up with company changes in the biotech world, but a recent published study in the Annals of Oncology, the official journal of the European Society for Medical Oncology (ESMO) includes highly intriguing results of an unusual combination for advanced pancreatic cancer of gemcitabine and the fully human monoclonal antibody (Mab) AGS-1C4D4. […]

Share Button

Momordica Charantia (Bitter Melon) Juice Shows Promise with Pancreatic Cancer Cells and in Mice

Researchers from the University of California at San Diego have published a recent study in the journal Carcinogenesis that showed that Bitter Melon Juice (BMJ) caused cell death in four lines of pancreatic cancer cells, and appeared to inhibit pancreatic cancer tumor activity in mice. The fruit of the vine Momordica Charantia is called by […]

Share Button
Page 25 of 31« First...1020...2324252627...30...Last »